Tuberculosis
887
63
87
602
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
122 trials with published results (14%)
Research Maturity
602 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
31 terminated out of 887 trials
95.1%
+8.6% vs benchmark
14%
122 trials in Phase 3/4
20%
122 of 602 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 602 completed trials
Clinical Trials (887)
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
Effect of Mycobacterial Infection on Immune Status
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Training Protocol on the Natural History of Tuberculosis
Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis
Shortened Regimen for Drug-susceptible TB in Children
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
TB Stigma in the UK: Patients Experiences and Everyday Responses
Collect Data From Patients Receiving Standardized Anti-tuberculosis Therapy, Collect Monitoring Data, and Evaluate Treatment Efficacy and Potential Adverse Reactions.
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
Alcohol Reduction Among People With TB and HIV in India
Xpert Active Case-finding Trial 3 (XACT-3)
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19